Roth Mkm Initiates Coverage on Cardiol Therapeutics (NASDAQ:CRDL)
Equities researchers at Roth Mkm initiated coverage on shares of Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report) in a report issued on Wednesday, MarketBeat reports. The firm set a “buy” rating and a $10.00 price target on the stock. Roth Mkm’s price target points to a potential upside of 400.00% from the company’s previous close. […]
More Stories
Wrapped Velas (WVLX) Price Reaches $0.0220 on Top Exchanges
Wrapped Velas (WVLX) traded flat against the US dollar during the 24 hour period ending at 11:00 AM E.T. on...
Salesforce (NYSE:CRM) Shares Down 0.4% Following Insider Selling
Salesforce, Inc. (NYSE:CRM – Get Free Report)’s stock price fell 0.4% during trading on Tuesday after an insider sold shares...
Axalta Coating Systems Ltd. (NYSE:AXTA) Short Interest Update
Axalta Coating Systems Ltd. (NYSE:AXTA – Get Free Report) saw a significant drop in short interest during the month of...
Eli Lilly and Company (NYSE:LLY) Shares Down 2.3% Following Insider Selling
Eli Lilly and Company (NYSE:LLY – Get Free Report)’s share price fell 2.3% on Tuesday following insider selling activity. The...
ProShares Ultra Semiconductors (NYSEARCA:USD) Shares Gap Down to $140.59
ProShares Ultra Semiconductors (NYSEARCA:USD – Get Free Report) gapped down before the market opened on Tuesday . The stock had...
Maiar DEX (MEX) Trading Up 5.9% Over Last Week
Maiar DEX (MEX) traded 6.2% higher against the U.S. dollar during the one day period ending at 11:00 AM E.T....